Ventana announces collaboration to develop companion diagnostics for ImmunoGen's targeted anticancer agents
30-Oct-2014 -
Ventana Medical Systems, Inc. announced it has entered into an agreement with ImmunoGen, Inc. to collaborate on the development of biomarker assays and a companion diagnostic immunohistochemistry (IHC) test for one or more of ImmunoGen's product candidates. Under this agreement, the companies ...
biomarker
companion diagnostics
ImmunoGen
+1